OTC product: maximum strength Zantac 150.
Swanson
Keith A
KA
College of Pharmacy, University of Oklahoma, Oklahoma City 73190, USA. Keith-Swanson@ouhsc.edu
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D004304:Dosage Forms; D004305:Dose-Response Relationship, Drug; D004348:Drug Labeling / Q000379:methods / Q000592:standards; D004349:Drug Packaging / Q000379:methods; D004415:Dyspepsia / Q000517:prevention & control; D005764:Gastroesophageal Reflux / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D004366:Nonprescription Drugs / Q000008:administration & dosage / Q000627:therapeutic use*; D011899:Ranitidine / Q000008:administration & dosage / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D004304:Dosage Forms; D004366:Nonprescription Drugs; D011899:Ranitidine